CDK4 and CDK6 play a central role in cell cycle regulation, dysregulation of the CDK4/CDK6 pathway as potential therapeutic targets for cancer treatment
Highly Selective CDK4 Bias
Potential for high tissue and brain penetration and better combinability
About
A seasoned team experienced in developing cancer medicines to create a fully integrated oncology company.